GILOTRIF vs HERNEXEOS

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Possible drug interaction. GILOTRIF and HERNEXEOS are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	GILOTRIF	HERNEXEOS
Rating	72/100	72/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	AFATINIB DIMALEATE	ZONGERTINIB
Manufacturer	Boehringer Ingelheim	Boehringer Ingelheim
Dosage forms	Tablet	Tablet
Drug class	—	—
Boxed warning	None	None
Treats	Non-Small-Cell Lung Carcinoma, Squamous Cell Carcinoma	Non-Small-Cell Lung Carcinoma

gilotrif hernexeos

Rating

72/100

Pharmacy pays

—

Type

Active ingredient

AFATINIB DIMALEATE

ZONGERTINIB

Manufacturer

Boehringer Ingelheim

Dosage forms

Tablet

Drug class

—

Boxed warning

None

Treats

Non-Small-Cell Lung Carcinoma, Squamous Cell Carcinoma

Non-Small-Cell Lung Carcinoma

Frequently asked questions

Which is better-rated, Gilotrif or Hernexeos?

Gilotrif and Hernexeos are tied at 3.6 out of 5 by our independent rating.

What is the difference between Gilotrif and Hernexeos?

Gilotrif contains Afatinib Dimaleate, while Hernexeos contains Zongertinib — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.